BPC-157 vs TB-500
What the research says about each, side by side. Every row comes from the studies and drug labels in the last row. More on each: BPC-157 and TB-500.
| BPC-157 | TB-500 | |
|---|---|---|
| Category | Investigational peptides | Investigational peptides |
| Evidence | Primarily preclinical research | Primarily preclinical research |
| FDA status | Not approved by the FDA. Products sold online as "research chemicals" aren't checked for purity, sterility or dose. | Not approved by the FDA. Products sold online as "research chemicals" aren't checked for purity, sterility or dose. |
| How it works | In animal studies it seems to help grow new blood vessels (via VEGF and nitric oxide), draw repair cells into injuries and protect the gut lining. Whether this applies to people is unknown. | It binds actin, part of the cell's internal skeleton, which helps cells migrate. It also seems to calm inflammation and support new blood vessel growth. |
| Half-life | Not established in people. In animals it's cleared from the blood within about half an hour. | Not established for injected TB-500. |
| Studied for |
|
|
| Sources |
|
